Find a Top Oncologist Near Me – Book an Appointment Instantly

Dr. Anushka Patel is a board-certified radiation oncologist and is an expert in using Intensity Modulated Radiation Therapy (IMRT), as well as Image Guided Radiation Therapy (IGRT), to treat a multitude of cancers including those of the breast, lung, head and neck, and gastrointestinal tract. Dr. Patel is experienced in the delivery of Stereotactic Body Radiation Therapy (SBRT) for intracranial, spinal, and lung treatments. She is also a radiation oncology attending for the Honor Health Dermatology Residency Program.

Dr. Patel joined Arizona Center for Cancer Care in 2014. She has published and presented at national meetings on SRS for brain metastases from breast cancer, SBRT for central lung lesions, and radiographic abnormalities detected at the time of CT simulation. 

Dr. Patel has been practicing in the Scottsdale and Deer Valley regions since 2009 and believes in taking a personalized and individualistic approach towards all her patients. She is known for going the above and beyond to ensure patients and their families have a full understanding of the diagnosis and overall treatment plan.

Dr. Patel is a member of the American Society for Therapeutic Radiology and Oncology, American Society for Clinical Oncology, American College of Radiation Oncology, and Radiological Society of North America. Dr. Patel has been honored as a “Top Doc” by Phoenix Magazine.

Patient Reviews:

"Dr. Anushka Patel is a fabulous Radiation Oncologist. She saved my life 2.5 years ago. Besides her knowledge and providing me with the best care she is so compassionate and comforting. She always listens, has thorough explanations and takes time with me. We need more physicians love me Dr. Patel." -Eileen

"Dr. Patel was very thorough and provided me an opportunity to ask as many questions as I needed to without feeling rushed! She truly cares about her patients and I look forward to her treatment plan!" -Jenifer

Arizona Center for Cancer Care is a cancer center without walls, offering the best doctors, best treatments, best technologies, and best research to give patients the best care possible. With offices in Avondale, Chandler, Gilbert, Glendale, Mesa, Phoenix, Scottsdale, Surprise, Anthem, Peoria, Fountain Hills, Wickenburg, Apache Junction, Sun City, Sun City West, Goodyear, Prescott Valley, and Tempe, Arizona, the multi-specialty practice cares for more than 30,000 patients across the Valley.

Arizona Center for Cancer Care specializes in treating many types of cancer, including multiple myeloma, colon, head and neck, breast, skin, and pancreatic, as well as brain cancer, lung cancer, and gastrointestinal cancer. 

The practice uses the most current treatment options available, including various forms of radiation oncology and medical oncology, and hematology. The center also includes experts in gynecologic oncology and breast surgery and has a newly diagnosed breast cancer clinic.

The board-certified radiation oncologists at Arizona Center for Cancer Care use positron emission tomography/computed tomography (PET/CT) imaging to reveal the presence and severity of cancer and create an effective treatment plan.

Dedicated to providing its patients with the most current drugs and therapies available, Arizona Center for Cancer Care participates in multiple clinical trials. 

Cancer is a disease of survivors, and Arizona Center for Cancer Care is keeping it that way.  

For comprehensive, high-quality cancer care, call Arizona Center for Cancer Care or schedule an appointment online today. Telemedicine appointments are available.

Nimi Tuamokumo, MD MPH graduated cum laude from Princeton University with a Bachelor of Arts degree in the Psychology. She received her M.D. from Yale University School of Medicine in New Haven, CT and her MPH degree from Harvard School of Public Health.

Dr. Tuamokumo completed an internship in the Department of Medicine at Mount Auburn Hospital in Cambridge, MA and a residency in Radiation Oncology at the Harvard Radiation Oncology Program. Dr. Tuamokumo specializes in Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT).

She is experienced in treating all types of malignancies. Dr. Tuamokumo has been with GHRO since completion of her residency in 2008. She has received many awards, including the National Institutes of Health Careers in Medicine Fellowship, American Cancer Society Outstanding Thesis Award, New England Cancer Society’s Daland Resident Award, NIH Cancer Education Grant, Etta S. Chidsey Award in Cancer Research.

Dr. Tuamokumo has published articles and given presentations on a range of topics including breast cancer, prostate cancer, pediatric cancer, and gastric cancer. She is a member of the Texas Medical Association, the American Society of Clinical Oncology, and the American Society for Therapeutic Radiology and Oncology. 

Dr. Theodore K. Yang received his undergraduate degree at The University of Texas at Austin in physics and went on to work as a medical physicist before attending medical school. He received his medical degree and completed residency training in radiation oncology at The University of Texas Medical Branch at Galveston (UTMB).

He then joined the UTMB faculty specializing in head and neck therapy and brachytherapy. Board certified in therapeutic radiology, Dr. Yang has practiced radiation oncology Houston since 1984.

Dr. Yang is a member of professional medical societies, including the Harris County Medical Society, Texas Medical Association, American Medical Association, ASTRO (American Society for Therapeutic Radiology and Oncology) and CADAH (Chinese American Doctors Association of Houston). 

Dr. Benjamin Ball grew up in a smaller town within the New York Tri-State area. As a young adult, he moved to Charlottesville, Virginia where he completed a double major in chemistry and biology at the University of Virginia, graduating with high honors. He remained at UVA for medical school, where his pre-clerkship GPA was top five in his class. He then completed his neurosurgical residency at the University of California, Irvine, where he spent a year completing an enfolded skull-base surgery fellowship. His surgical interests include tumors, spine, and trauma. In his free time, he enjoys watching movies, reading science fiction books, attending local comedy shows, and watching UVA Men’s Basketball dominate.

Founder & Medical Director
Angelique E Richardson MD PhD | The Center for Phenomenal Health & Wellness Inc.
San Diego, California

Angelique E. Richardson, MD, PhD, is a board-certified medical oncologist, physician-scientist, and nationally recognized leader in breast cancer care, cancer health equity, and women’s health across the lifespan. She is the Founder and Medical Director of The Center for Phenomenal Health & Wellness, a concierge women’s health practice in San Diego dedicated to menopause, perimenopause, cancer survivorship, and long-term wellness for women.

Dr. Richardson brings together academic rigor, clinical excellence, and deeply personalized care, offering women a level of expertise typically found at major academic cancer centers—delivered in a thoughtful, relationship-centered private practice setting.

Prior to founding her private practice, Dr. Richardson served as an Associate Professor of Medicine at the University of California, San Diego (UCSD) within the Comprehensive Breast Health Center. There, she specialized in the diagnosis and treatment of breast cancer while leading and contributing to clinical trials, translational research, and community-engaged cancer equity initiatives.

She has served as Principal Investigator on multiple national and industry-sponsored clinical trials, including Phase I–III breast cancer studies, and has been actively involved in advancing access to clinical trials for historically underserved populations.

Dr. Richardson is a physician-scientist with dual MD and PhD training, holding a doctorate in Microbiology and Molecular Genetics with an emphasis in cancer biology. Her research has focused on:

• Breast cancer biology and signaling pathways

• Cancer health disparities and survival inequities

• Biomarkers in breast cancer prognosis and treatment response

• Implementation of patient-reported outcomes in underserved populations

She has authored peer-reviewed publications, contributed to textbook chapters, and presented her work nationally and internationally through organizations such as AACR, ASCO, SABCS, and NIH-affiliated forums.

Her work and leadership have been recognized through numerous honors, including:

• Robert A. Winn Diversity in Clinical Trials Leadership Award

• Merck Investigator Studies Program (MISP) funding

• Early Stage Investigator Awards

• National leadership roles in cancer equity and survivorship initiatives

In addition to her oncology expertise, Dr. Richardson is deeply committed to women’s health beyond cancer treatment. She specializes in helping women navigate:

• Perimenopause and menopause

• Hormonal and non-hormonal symptom management

• Long-term survivorship and quality-of-life optimization

• Wellness strategies for women at high risk for breast cancer

• Care planning for women who are not candidates for standard hormone therapy

Her approach is evidence-based, individualized, and deeply informed by her years caring for breast cancer survivors, making her uniquely positioned to guide women through complex hormonal transitions safely and thoughtfully.

Dr. Richardson earned her Doctor of Medicine (MD) and PhD from Loma Linda University, where her doctoral research examined molecular drivers of aggressive breast cancer biology. She completed:

• Internal Medicine Residency at White Memorial Medical Center (Los Angeles)

• Hematology/Oncology Fellowship at Penn State College of Medicine

• Advanced Clinical Breast Oncology training at the University of Miami

Dr. Richardson serves on numerous local, state, and national advisory boards, including:

• Susan G. Komen National Advisory Board and Leadership Council

• California Breast Cancer Research Council (University of California)

• American Society of Clinical Oncology (ASCO)

• American College of Physicians (ACP)

• National Medical Association (NMA)

She is a frequent invited speaker for professional conferences, community organizations, and national educational forums, and remains deeply engaged in mentorship, advocacy, and community outreach.

Dr. Richardson believes that women deserve time, expertise, and care that honors the whole person—not just a diagnosis. Her practice model is intentionally designed to provide:

• Longer visits

• Direct physician access

• Thoughtful, personalized care plans

• Preventive, survivorship-focused medicine

Kamlesh Kumar Sankhala MD (also known as Dr. Kumar by his patients and colleagues) is a Medical Oncologist at Cedars-Sinai Medical Center in Los Angeles, California, and Director of Precision NextGen Oncology and Research Center, an independent center focused on treatment of complex, rare cancer and Sarcomas, as well as, clinical research in Oncology for expedited drug development and clinical research. Precision NextGen Oncology and Research Center  focuses on care for patients with Advanced Cancers who are refractory to conventional treatments. We provide care to these patients with multi- institutional coordinated care and access to novel and next generation therapies with or without clinical trials.

Dr. Sankhala specializes in clinical research and has pioneered a niche in treatments for patients with advanced and complex malignancies refractory to conventional treatments, along with rare cancer such as sarcomas.

Dr. Sankhala received his medical degree at the University of Rajasthan, India and undertook his internal medicine residency and fellowship training in oncology at the University of Texas Health Science Center. He had two years of additional fellowship in Oncology Drug Development at the University of Texas’s Institute for Drug Development. He was a clinical faculty at the University of Texas’s Health Science Center, and Clinical Investigator at the Institute for Drug Development (IDD). He also served as team leader for the University’s Sarcoma Program. Dr. Sankhala has served as the Co-Director, Sarcoma Medical Oncology and the Director of Clinical Research and Experimental Therapeutics Cedars-Sinai Medical Center’s THO.

Besides his Medical Oncology practice in advanced refractory cancers, Dr. Sankhala’s research focuses on translational research of novel anti-cancer agents and on studying the pre-clinical and clinical aspects of these agents. With an esteemed background in novel drug research and phase-1 clinical trials, Dr. Sankhala has evolved into a physician devoted to the translational research of novel anti-cancer agents by applying himself to the study and evaluation of pre-clinical and clinical implications of new agents in patients with advanced cancers. He has developed a clinical proficiency in using novel anticancer drugs for patients with advanced malignancies and has optimized existing chemotherapeutic agents by reducing toxicities and increasing efficacy, thereby yielding better responses to anti-cancer therapies. Dr. Sankhala's extensive clinical research background includes serving as the principal investigator and sub-investigator in more than 250 Phase-1 and other Oncology clinical trials.

Dr. Sankhala has served on advisory boards for many pharmaceutical companies to design, implicate, and conduct research on many novel oncology therapeutic molecules and has also helped several other companies to optimize and find the marketplace for novel therapies. He has also served as a member of Protocol Review and Management Committee (PRMC) and institutional review board (IRB) at Samuel Oschin Cancer Center at Cedars-Sinai Cancer Institute in Los Angeles.

Dr. Sankhala has been a reviewer of reputed journals in the field of Oncology such as the British Journal of Cancer, Cancer Chemotherapy & Pharmacology, Journal of Medical Case Report, Onkologie, and Bone Marrow Transplantation. He is an editorial board member for the Journal of Cancer Science, and Therapy and Chemotherapy.

Dr. Sankhala’s has authored and co-authored 71 numerous articles, and abstracts in journals including Journal of Clinical Oncology, Clinical Cancer Research, Oncology immunology, Investigational New Drugs, Cancer Journal, Expert Review in Hematology, Cancer chemotherapy and Pharmacology, JAMA Oncology, Clinical Breast Cancer, Cancer Chemotherapy Pharmacology, Molecular Cancer Therapeutics, Leukemia Lymphoma, Current Drug Target, Expert Opinion in Investigational Drugs, Future Oncology, Target Oncology, Expert opinion in Drug Metabolism and Toxicology, and Clinical Advancement in Hematology Oncology.

He is the recipient of the American Society of Clinical Oncology Foundation’s Merit Award and the AACR- NCI scholarship for Molecular Biology in Clinical Oncology. 

He has presented in many major national and international meetings including the American Society of Clinical Oncology (ASCO), Connective Tissue Oncology Society (CTOS), Japan’s Sarcoma Society, and many others. 

Beside Cedars-Sinai Medical Center, Dr. Sankhala has affiliations with various esteemed health facilities across Los Angeles, including Univversity of California at Los Angeles, University of Southern California and Providence Saint John's Health Center.

Dr. Sankhala’s academic interests extend to progressive fields including Healthcare Utilization Management, Managed Care, Consumer-Directed Healthcare, Healthcare Economics, and Medical Oncology Trend Management.